TrademarkDir
HITMAB
LIVE

Serial Number

79316062

Owner

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Attorney

Scot A. Duvall

Filing Date

Apr 26, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HITMAB Trademark

Serial Number: 79316062 • Registration: 6854569

HITMAB is a trademark filed by Zhuhai Trinomab Pharmaceutical Co., Ltd. on April 26, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Zhuhai Trinomab Pharmaceutical Co., Ltd. (9 trademarks)

Rm.110, 1/F., Plant Building 6,

Entity Type: 99

TRINOMAB BIOTECH CO., LTD

Room 110, 1st Floor, Workshop 6,

Entity Type: 99

Trademark Details

Filing Date

April 26, 2021

Registration Date

September 27, 2022

Published for Opposition

July 12, 2022

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 22, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 7, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 18, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 18, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Jul 18, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 29, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 6, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 6, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 6, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 6, 2022 CNEA
DATA MODIFICATION COMPLETED
Jun 3, 2022 DMCC
ASSIGNED TO LIE
Jun 3, 2022 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2022 TROA
REFUSAL PROCESSED BY IB
Feb 6, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Dec 27, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 22, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 27, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 22, 2021 REPR

Related Trademarks

More from this Owner

ULTRAHITMAB

ULTRAHITMAB

HITMAB2.0 logo

HITMAB2.0

SDUOTUAL

SDUOTUAL

XINSITOL

XINSITOL

XINSITOL

XINSITOL

XINSITOL

XINSITOL